Literature DB >> 21688383

Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?

Tan To Cheung1, See Ching Chan, Chi Lai Ho, Kenneth Siu Ho Chok, Albert Chi Yan Chan, William Wei Sharr, Kelvin Kwok Chai Ng, Ronnie Tung Ping Poon, Chung Mau Lo, Sheung Tat Fan.   

Abstract

Microvascular invasion is a poor prognostic indicator of the recurrence of hepatocellular carcinoma (HCC) after surgical treatment. Positron emission tomography (PET) with [(18) F]fludeoxyglucose ([(18) F]FDG) as a tracer has been employed to predict the prognosis before surgery for various kinds of tumors, but it has not been found to be sensitive enough for HCC. Thus, [(11) C]acetate has been adopted as an additional tracer. This study was designed to evaluate the ability of dual-tracer PET ([(18) F]FDG and [(11) C]acetate) to predict microvascular invasion before liver resection or transplantation. Fifty-eight HCC patients who were preoperatively examined with whole-body dual-tracer PET were studied. Twenty-five patients were [(18) F]FDG-positive, and 56 were [(11) C]acetate-positive. The sensitivity of [(18) F]FDG in detecting primary HCC was 43%, and the sensitivity of [(11) C]acetate was 93%. Twenty-nine patients had HCC with microvascular invasion according to the final pathological examination. The sensitivity, specificity, positive predictive value, and negative predictive value of [(18) F]FDG PET in predicting microvascular invasion were 55.2%, 69%, 64%, and 60.6%, respectively; the corresponding rates for [(11) C]acetate PET were 93.1%, 0%, 48.2%, and 0%. The factors associated with HCC recurrence, which included multifocal involvement, a large tumor size, microsatellite lesions, poor HCC differentiation, and an advanced stage of disease, were analyzed and compared with positive PET results. A tumor size greater than 5 cm was significantly associated with positive [(18) F]FDG PET results; [(11) C]acetate was not associated with poor prognostic indicators. Preoperative [(18) F]FDG PET may predict microvascular invasion. The addition of [(11) C]acetate improves the overall sensitivity of PET, but it has no incremental value in predicting microvascular invasion.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688383     DOI: 10.1002/lt.22362

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  29 in total

1.  Microvascular invasion in hepatocellular carcinoma.

Authors:  Emre Ünal; İlkay Sedakat İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

2.  Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience.

Authors:  Tan To Cheung; Ronnie T P Poon; Wing Chiu Dai; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

3.  Liver Resection for De Novo Hepatocellular Carcinoma Complicated by Pyogenic Liver Abscess: A Clinical Challenge.

Authors:  Kenneth S H Chok; Tan To Cheung; Albert C Y Chan; Wing Chiu Dai; See Ching Chan; Chung Mau Lo
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

Review 4.  Liver transplantation for hepatocellular carcinoma.

Authors:  See Ching Chan
Journal:  Liver Cancer       Date:  2013-08       Impact factor: 11.740

Review 5.  When to consider liver transplantation in hepatocellular carcinoma patients?

Authors:  Ka Wing Ma; Tan To Cheung
Journal:  Hepat Oncol       Date:  2017-07-06

Review 6.  The emerging role of positron emission tomography in hepatocellular carcinoma.

Authors:  Suraiya R Dubash; Oluwagbemiga A Idowu; Rohini Sharma
Journal:  Hepat Oncol       Date:  2015-04-27

Review 7.  Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes.

Authors:  Chih-Che Lin; Chao-Long Chen
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

Review 8.  Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation.

Authors:  Wong Hoi She; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-14

9.  A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.

Authors:  Tsung-Han Wu; Etsuro Hatano; Kenya Yamanaka; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Yasuhiro Fujimoto; Takashi Nitta; Masaki Mizumoto; Akira Mori; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

Review 10.  Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation.

Authors:  See Ching Chan; Sheung Tat Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.